Clinical Trials on Mycosis Fungoides

Total 7577 results

University Hospital Inselspital, Berne

Completed

Surveillance of Fungal Infections During Construction Activity

Aspergillosis

Switzerland
Capital Medical University

Unknown

Clinical Significance of Smear or Culture Positive for Candida Spp. From Sputum Three Times a Week

Pulmonary Candidiasis

China
National Cancer Institute (NCI)

Completed

Caspofungin to Prevent Candidiasis in Adults in Hospital Intensive Care Units

Candidiasis

United States
Assiut University

Completed

THYME AND CARVACROLL Nanoparticle Effect on Fungi

Aspergillosis

Egypt
Astellas Pharma Inc

Completed

Study of FK463 for the Treatment of Invasive Aspergillosis

Aspergillosis

United Kingdom, Austria, France, Germany, Italy, Poland, Spain, Sweden
Pfizer

Terminated

A Study Of The Safety, Tolerability And Effective Of Voriconazole For The Treatment Of Serious Candida Infection And Candida Infection Of The Throat In Pediatric Patients

Candidiasis

Hong Kong, Hungary, China, Czech Republic, Mexico, Philippines, Poland, Slovakia
Merck Sharp & Dohme LLC

Completed

MK0991 in Combination With Standard Antifungal Agent(s) for the Treatment of Salvage Invasive Aspergillosis (0991-037)

Aspergillosis
National Institute of Allergy and Infectious Diseases...

Terminated

Caspofungin Study for Fungal Infections in Adults in Critical Care Settings

Candidiasis

United States
Pfizer

Completed

Anidulafungin Plus Voriconazole Versus Voriconazole For The Treatment Of Invasive Aspergillosis

Aspergillosis

United States, Australia, Canada, Greece, Belgium, Germany, Korea, Republic of, Poland, Russian Federation, Spain, Turkey, Thailand, Brazil, Czech Republic, France, India, Italy, Netherlands, Peru, Portugal, Singapore, Switzerland, ... and more
Pfizer
Vicuron Pharmaceuticals

Completed

A Safety & Effectiveness Study of Intravenous Anidulafungin With AmBisome® for Treatment of Invasive Aspergillosis (IA).

Aspergillosis

United States
Janssen Pharmaceutica

Completed

An Efficacy and Safety Study of Miconazole and Hydrocortisone Cream in the Treatment of Vulvar Candidiasis

Vulva; Candidiasis
University of Arkansas

Withdrawn

Trial of Combination Antifungal Therapy (Vori+Mica vs. Vori+Placebo) in Invasive Aspergillosis

Aspergillosis

United States
Pfizer

Terminated

Study to Test the Combination of Voriconazole and Anidulafungin in Patients Who Have, or Are Thought to Have, Invasive Aspergillosis and Who Are Unable to Take a Common Antifungal Therapy (Polyene)

Aspergillosis

United States
Fred Hutchinson Cancer Center
National Cancer Institute (NCI)

Completed

Tacrolimus and Mycophenolate Mofetil in Preventing Graft-Versus-Host Disease in Patients Who Have Undergone Total-Body Irradiation With or Without Fludarabine Phosphate Followed by Donor Peripheral Blood Stem Cell Transplant for Hematologic Cancer

Primary Myelofibrosis | Polycythemia Vera | Essential Thrombocythemia | Stage I Multiple Myeloma | Stage II Multiple Myeloma | Stage III Multiple Myeloma | Recurrent Adult Acute Myeloid Leukemia | Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue | Nodal Marginal Zone B-cell... and other conditions

United States, Italy
National Cancer Institute (NCI)

Active, not recruiting

Talimogene Laherparepvec and Nivolumab in Treating Patients With Refractory Lymphomas or Advanced or Refractory Non-melanoma Skin Cancers

Sezary Syndrome | Refractory T-Cell Non-Hodgkin Lymphoma | Merkel Cell Carcinoma | Anaplastic Large Cell Lymphoma, ALK-Positive | Extramammary Paget Disease | Recurrent T-Cell Non-Hodgkin Lymphoma | Recurrent Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma | Refractory Mature T-Cell and NK-Cell Non-Hodgkin... and other conditions

United States
Basilea Pharmaceutica

Completed

A Drug-Drug Interaction Study of CYP3A4 Inhibition and Pan-CYP Induction on APX001

Fungal Infection

Netherlands
University of Maryland, Baltimore

Completed

Itraconazole Oral Absorption

Fungal Infection

United States
Pfizer

Completed

Vfend Special Investigation For Prophylaxis

Fungal Infection
University Hospital, Grenoble

Completed

Mucormycosis in ICU (ZygoRéa)

Mucormycosis

France
Assistance Publique - Hôpitaux de Paris

Completed

Pilot Study of High Dose Liposomal Amphotericin B Efficacy in Initial Zygomycosis Treatment (AMBIZYGO)

Zygomycosis

France
Almirall, S.A.

Completed

Efficacy and Safety of LAS41003 in the Treatment of Intertriginous Candida Infections

Candidiasis

Germany
Children's Hospital Medical Center, Cincinnati
Astellas Pharma Inc

Completed

Alternate Day Micafungin: A PK Study in Pediatric Patients

Fungal Infection

United States
Children's Hospital of Philadelphia
Eunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaborators

Completed

Fluconazole Pharmacokinetics in Infants

Fungal Infection

United States
Pfizer
Mclean Hospital

Completed

Assessment of Voriconazole Penetration Into the Brain by Fluorine-Magnetic Resonance Spectroscopy

Fungal Infection
Basilea Pharmaceutica

Completed

A Study to Assess the Mass Balance Recovery and Metabolite Profile & Identification of [14C]-APX001 in Healthy Males

Fungal Infection

United Kingdom
Lundquist Institute for Biomedical Innovation at...
Novartis; Gilead Sciences; Astellas Pharma Inc

Completed

The Deferasirox-AmBisome Therapy for Mucormycosis (DEFEAT Mucor) Study

Mucormycosis

United States
National Institute of Allergy and Infectious Diseases...

Terminated

Safety and Pharmacokinetics of Rezafungin

Fungal Infection

United States
Radboud University Medical Center

Completed

Pharmacokinetics of Fluconazole IV as Prophylaxis or Therapy to ICU Patients (PACIFIC)

Candidiasis

Netherlands
Merck Sharp & Dohme LLC

Terminated

A Pharmacokinetic Analysis of Posaconazole in Lung Transplant Recipients (MK-5592-105) (PAPAL)

Fungal Infection
Merck Sharp & Dohme LLC

Completed

Documented Candida or Aspergillus Infections in Pediatric Patients (0991-043)

Candidiasis | Aspergillosis
Amir Mortazavi
National Cancer Institute (NCI); Arno Therapeutics

Completed

AR-42 in Treating Patients With Advanced or Relapsed Multiple Myeloma, Chronic Lymphocytic Leukemia, or Lymphoma

Stage III Multiple Myeloma | Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue | Nodal Marginal Zone B-cell Lymphoma | Recurrent Adult Burkitt Lymphoma | Recurrent Adult Diffuse Large Cell Lymphoma | Recurrent Adult Diffuse Mixed Cell Lymphoma | Recurrent Adult Diffuse... and other conditions

United States
National Cancer Institute (NCI)

Completed

Vorinostat in Treating Patients With Metastatic or Unresectable Solid Tumors or Lymphoma and Liver Dysfunction

Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue | Nodal Marginal Zone B-cell Lymphoma | Recurrent Adult Burkitt Lymphoma | Recurrent Adult Diffuse Large Cell Lymphoma | Recurrent Adult Diffuse Mixed Cell Lymphoma | Recurrent Adult Diffuse Small Cleaved Cell Lymphoma and other conditions

United States
Shanghai Jiao Tong University School of Medicine

Recruiting

Escalation Antifungal Prophylaxis for Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation

Fungal Infection

China
Basilea Pharmaceutica

Completed

Safety, Pharmacokinetics, Bioavailability, Food Effect, Drug-Drug Interaction Study of APX001 Administered Orally

Fungal Infection

Netherlands
Basilea Pharmaceutica

Completed

Study to Assess Safety, Tolerability and Pharmacokinetics of APX001 Administered by Intravenous Infusion to Healthy Subjects

Fungal Infection

Netherlands
Centre Hospitalier Universitaire de Besancon

Completed

Prospective Evaluation of a New Molecular Tool for Early Diagnosis of Mucormycosis (MODIMUCOR)

Mucormycosis

France
Scynexis, Inc.
Inncelerex

Completed

ADME Study of [14C]-Ibrexafungerp in Healthy Male Subjects

Fungal Infection

United Kingdom
Masonic Cancer Center, University of Minnesota

Completed

MT2013-37R: Voriconazole Monitoring in Pediatric Stem Cell Transplant Patients

Fungal Infection

United States
Seoul National University Hospital

Completed

A Study to Evaluate the Appropriateness of the Voriconazole Dosing Regimen

Fungal Infection

Korea, Republic of
Southeast University, China
QLT Inc.

Unknown

A Multicenter Observational Study of Invasive Candida Infections Among ICU Patients in China (china-scan)

Candidiasis

China
University Hospital, Udine, Italy
Catholic University of the Sacred Heart

Completed

Seifem Surveillance of Antifungal Combination Therapy In Hematologic Italian Centers (SEIFEM COMBO)

Fungal Infection

Italy
Pfizer
McLean Hospital. Belmont, MA.

Completed

To Determine The Amount Of Voriconazole In The Brain After 2 Loading Doses And 3 Maintenance Doses Over 3 Days

Infections, Fungal

United States
National Cancer Institute (NCI)

Completed

Voriconazole to Treat Fungal Infections

Mycoses

United States
F2G Biotech GmbH
Iqvia Pty Ltd; Shionogi

Recruiting

Olorofim Aspergillus Infection Study (OASIS)

Invasive Aspergillosis

United States, Taiwan, Belgium, Spain, Italy, Turkey, New Zealand, China, Canada, Netherlands, Australia, Brazil, Singapore, Israel, France, Thailand, Germany, Japan, Korea, Republic of, United Kingdom
Biosergen AS
Nucleus Network Ltd; Select Pharma Pty Ltd; Greenlight Clinical

Recruiting

A Study to Assess the Safety, Tolerability and Pharmacokinetics of BSG005.

Invasive Fungal Infections

Australia
Basilea Pharmaceutica

Completed

A Bioequivalence Study of APX001 High-load and Low-load Tablets

Invasive Fungal Infections

United States
Merck Sharp & Dohme LLC

Completed

Posaconazole (MK-5592) Intravenous and Oral in Children With Invasive Aspergillosis (IA) (MK-5592-104)

Invasive Aspergillosis

Belgium, United States, Greece, Hungary, Israel, Italy, Korea, Republic of, Mexico, Peru, Russian Federation
Shandong University

Completed

Population Pharmacokinetics and Dose Optimization of Caspofungin in Adolescents

Invasive Fungal Infections

China
Merck Sharp & Dohme LLC

Completed

Assessing the Safety and Efficacy of MK-5592 (Posaconazole) in Japanese Participants With Fungal Infection (MK-5592-101)

Aspergillosis
Islamia University of Bahawalpur

Completed

Molecular Characterization of Candida Auris (OC)

Oral Fungal Infection

Pakistan

Clinical Trials on Mycosis Fungoides

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Bulgaria

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations